KRAS and head and neck squamous cell carcinoma: In a population-based case-control study conducted in the US by Christensen et al., the KRAS-LCS6 variant genotype (rs61764370) was not associated with the overall risk of head and neck squamous cell carcinoma, but was associated with a significantly reduced survival time [34].